Standout Papers

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failu... 2020 2026 2022 2024219
  1. Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure (2020)
    Jordan Gauthier, Alexandre V. Hirayama et al. Blood
  2. Diagnosis and Treatment of Chronic Lymphocytic Leukemia (2023)
    Mazyar Shadman JAMA

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
3 intermediate papers

Works of Mazyar Shadman being referenced

PB1890: ZANUBRUTINIB IN ACALABRUTINIB-INTOLERANT PATIENTS (PTS) WITH B-CELL MALIGNANCIES
2022
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
2020 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Mazyar Shadman 1303 966 626 211 2.1k
Emmanuel Bachy 1230 1134 422 182 2.1k
Paolo F. Caimi 1404 914 398 208 2.1k
Timothy S. Fenske 1615 1186 613 162 2.6k
Jun Zhu 1391 1297 541 173 2.4k
Brian T. Hill 1139 926 762 222 2.6k
Nilanjan Ghosh 1338 891 398 156 2.3k
Javier Muñoz 1147 847 518 129 1.7k
Mark Roschewski 1304 1375 595 128 2.8k
Julio C. Chávez 2250 1215 517 219 3.0k
Paolo Strati 921 874 1092 136 2.4k

All Works

Loading papers...

Rankless by CCL
2026